Comparison of CD34+ cell numbers and colony growth before and after cryopreservation of peripheral blood progenitor and stem cell harvests: influence of prior chemotherapy

Transfusion. 1997 Oct;37(10):1050-7. doi: 10.1046/j.1537-2995.1997.371098016444.x.

Abstract

Background: Quantitative determination of hematopoietic progenitor cells is a major issue in peripheral blood progenitor and stem cell collection and transfusion, although the extent is still an object of discussion.

Study design and methods: In 116 leukapheresis collections from 42 patients, immunophenotyping for CD34+ cells, evaluation of in vitro proliferative capacity by a colony-forming unit-granulocyte-macrophage (CFU-GM) assay, and viability assessment by trypan blue exclusion were performed before and after storage in liquid nitrogen at -196 degrees C.

Results: Before storage, the median number of CD34+ cells was 1.46 x 10(6) (range, 0.01-54.05 x 10(6)) per kg of body weight (BW). There was no significant difference between precryopreservation and postcryopreservation numbers. The median number of CFU-GM was 2.25 x 10(5) (range, 0.02-157.49 x 10(5)) per kg of BW before cryopreservation and significantly (p < 0.001) lower, 0.83 x 10(5) (range, 0-220.36 x 10(5)) per kg of BW, after cryopreservation. The correlation coefficient of prestorage and poststorage values was 0.92. The median ratio of poststorage and prestorage values was 42.3 percent (0-304.8%). Male patients who underwent intense chemotherapy (> 5 cycles) showed a significantly lower ratio of postcryopreservation and precryopreservation CFU-GM values than other patients (p = 0.0047). A strong linear correlation was determined between the number of CD34+ cells per kg of BW and the number of CFU-GM per kg of BW before and after cryopreservation. A viability below 50 percent predicted a high loss of in vitro proliferative capacity, while a viability above 50 percent did not correlate with a high ratio of CFU-GM from after and before cryopreservation.

Conclusion: A good correlation between the variables used for characterization of peripheral blood progenitor cells--the number of CD34+ cells and the number of CFU-GM--was observed. Viability assessment by trypan blue exclusion does not seem to be a substitute for assays evaluating in vitro proliferative capacity.

Publication types

  • Comparative Study

MeSH terms

  • Adult
  • Antigens, CD34 / analysis*
  • Blood Transfusion
  • Cell Count
  • Cell Survival
  • Cryopreservation
  • Drug-Related Side Effects and Adverse Reactions
  • Female
  • Granulocytes / cytology
  • Hematopoietic Stem Cell Transplantation*
  • Hematopoietic Stem Cells / drug effects
  • Hematopoietic Stem Cells / immunology*
  • Humans
  • Leukocytes, Mononuclear / cytology
  • Leukocytes, Mononuclear / immunology
  • Macrophages / cytology
  • Male
  • Middle Aged
  • Stem Cells / cytology
  • Time Factors

Substances

  • Antigens, CD34